Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1Phase 1 1

Status

Terminated 4Completed 4Unknown 2Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 3Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Uterine Cervical Neoplasms 31Prostatic Neoplasms 17Breast Neoplasms 8Sarcoma 6Vaginal Neoplasms 4Neoplasms 4Endometrial Neoplasms 4Vulvar Neoplasms 3Uterine Neoplasms 3Lung Neoplasms 3Carcinoma, Ductal, Breast 3Radiation Injuries 2Neuroectodermal Tumors, Primitive, Peripheral 2Gliosarcoma 2Glioblastoma 2Esophageal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Breast Carcinoma In Situ 2Anemia 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Retinoblastoma 1Recurrent Head and Neck Carcinoma 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Neoplasms × Brachytherapy × Clear all
NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 13 charts
GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT01851772 2021-01-12

Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer

Xoft, Inc.

Phase NA Completed
3 enrolled 6 charts
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

NCT01017549 2020-08-13

Post Market Study Using the Xoft Axxent System

Xoft, Inc.

Phase NA Completed
44 enrolled 5 charts
Breast

Breast Neoplasms, Neoplasms

NCT01485731 2015-06-03

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

University of Miami

Phase 1 Completed
8 enrolled
Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡